PUBLISHER: IMARC | PRODUCT CODE: 1541537
PUBLISHER: IMARC | PRODUCT CODE: 1541537
The global chondroitin sulfate market size reached US$ 1.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.1 Billion by 2032, exhibiting a growth rate (CAGR) of 3.2% during 2024-2032.
Chondroitin sulfate (CS) is a water-soluble polymer comprising alternating N-Acetylgalactosamine and glucuronic acid, which is naturally found in the cartilage, bone and cornea of animals. CS (C6H13NO5) is anti-atherogenic, inflammatory, thrombogenic and assists in the performance of coagulant activities. Consequently, it is utilized in oral delivery of insulin, proteins and peptides and as a skin substitute and biomaterial for wound healing in the healthcare sector.
CS acts as a precursor for inhibiting degradation, stimulating synthesis and improving the healing of articular cartilage. This represents one of the primary factors escalating the demand for CS-based injectable hydrogels in cartilage tissue engineering for fabricating purposes. Moreover, as it is an enzymatically biodegradable polysaccharide and has high water solubility and lack of mechanical stability, CS is modified with materials like collagen to be utilized in scaffold matrices and other drug delivery applications. Furthermore, it is being used in dietary supplements for relieving pain and disability of individuals with musculoskeletal pathologies or osteoarthritis. In line with this, CS serves as a template for generating hydroxyapatite nanocrystals, thereby contributing to the market growth. It is also gaining traction as an antistatic agent in the cosmetics industry for manufacturing hair conditioning products.
IMARC Group provides an analysis of the key trends in each sub-segment of the global chondroitin sulfate market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on source, form and application.
Bovine
Swine
Poultry
Shark
Others
Powder
Tablet
Others
Pharmaceuticals and Nutraceuticals
Animal Feed
Personal Care and Cosmetics
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Bioiberica S.A.U., BRF S.A., HeBei SanXin Industrial Group, Maypro Industries Inc., Merck KGaA, Pacific Rainbow International Inc., Qingdao Wantuming Biological Products Co. Ltd., Seikagaku Corporation, Sino Siam Biotechnique Company Limited, Sioux Pharm Inc., Synutra International Inc. and ZPD A/S.